Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,247 | 41,750 | 22,342 | 31,155 | 4,418 |
| Marketable Securities | 40,323 | 27,839 | 39,186 | 19,542 | 33,040 |
| Receivables | 30,227 | 33,722 | 11,982 | 39,128 | 4,556 |
| Inventories | 898 | 6,281 | N/A | N/A | N/A |
| Other current assets | 719 | 374 | 377 | 931 | 0 |
| TOTAL | $87,419 | $111,022 | $75,025 | $91,705 | $45,790 |
| Non-Current Assets | |||||
| PPE Net | 1,929 | 3,872 | 4,881 | 5,294 | 3,029 |
| Investments And Advances | 11,771 | 24,670 | 1,786 | 34,311 | 8,778 |
| Intangibles | 0 | 0 | 0 | 0 | 291 |
| Other Non-Current Assets | 8,328 | 2,626 | 3,001 | 11,407 | 10,598 |
| TOTAL | $22,028 | $31,168 | $9,667 | $51,012 | $22,696 |
| Total Assets | $109,447 | $142,190 | $84,692 | $142,717 | $68,485 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,201 | 18,070 | 5,266 | 19,771 | 5,887 |
| Accrued Expenses | 17,302 | 16,634 | 9,237 | 3,688 | 2,148 |
| TOTAL | $28,000 | $37,253 | $17,108 | $28,118 | $10,735 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,497 | 2,549 | 2,605 | 4,658 | 2,700 |
| TOTAL | $15,944 | $18,671 | $21,158 | $49,694 | $36,596 |
| Total Liabilities | $43,944 | $55,924 | $38,265 | $77,812 | $47,330 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,044 | 43,957 | 38,331 | 38,081 | 29,343 |
| Common Shares | 450 | 439 | 383 | 380 | 293 |
| Retained earnings | -296,572 | -262,719 | -249,268 | -224,536 | -195,481 |
| Other shareholders' equity | 105 | -26 | 103 | 378 | 32 |
| TOTAL | $65,503 | $86,266 | $46,426 | $64,905 | $21,155 |
| Total Liabilities And Equity | $109,447 | $142,190 | $84,692 | $142,717 | $68,485 |